Intercure Ltd.
INCRNasdaq
$0.92
↓ -4.4%Jul 17 close · end-of-day
Price
1Y↓ -38.9%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
No screener snapshot for this ticker.
Company profile
InterCure Ltd. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector.
- CEO
- Alexander Rabinovitch
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 350
- Website
- intercure.co
Earnings
No reported earnings periods on file.
Financial statements
No annual data.
No quarterly data.
Company news
Mar 3, 2026
Feb 19, 2026
- 151d agoInterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Millionfinance.yahoo.com
- 151d agoInterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Millionfinance.yahoo.com
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.